ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,311 | -72.6% | 25,121 | +6.0% | 0.00% | – |
| Q2 2023 | $12,082 | -20.9% | 23,691 | -2.3% | 0.00% | – |
| Q1 2023 | $15,272 | -4.2% | 24,242 | -1.3% | 0.00% | – |
| Q4 2022 | $15,939 | -58.1% | 24,556 | +11.2% | 0.00% | – |
| Q3 2022 | $38,000 | +18.8% | 22,092 | -15.3% | 0.00% | – |
| Q2 2022 | $32,000 | +128.6% | 26,090 | -0.8% | 0.00% | – |
| Q1 2022 | $14,000 | -51.7% | 26,291 | -2.8% | 0.00% | – |
| Q4 2021 | $29,000 | -43.1% | 27,040 | -2.7% | 0.00% | – |
| Q3 2021 | $51,000 | -29.2% | 27,802 | +2.3% | 0.00% | – |
| Q2 2021 | $72,000 | -27.3% | 27,168 | -1.4% | 0.00% | – |
| Q1 2021 | $99,000 | +35.6% | 27,552 | -5.2% | 0.00% | – |
| Q4 2020 | $73,000 | +5.8% | 29,078 | +5.4% | 0.00% | – |
| Q3 2020 | $69,000 | -28.1% | 27,577 | -5.5% | 0.00% | – |
| Q2 2020 | $96,000 | -35.1% | 29,185 | -51.8% | 0.00% | – |
| Q1 2020 | $148,000 | -42.4% | 60,510 | +10.9% | 0.00% | – |
| Q4 2019 | $257,000 | +72.5% | 54,555 | +56.4% | 0.00% | – |
| Q3 2019 | $149,000 | – | 34,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |